PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
5.46 - 5.64
4.95 - 8.28
2.0K / 2.4K (Avg.)
-282.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-8.41%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-7.38%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
18.84%
Positive EBIT growth while VALMT.HE is negative. John Neff might see a substantial edge in operational management.
18.84%
Positive operating income growth while VALMT.HE is negative. John Neff might view this as a competitive edge in operations.
37.56%
Net income growth of 37.56% while VALMT.HE is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
33.33%
EPS growth of 33.33% while VALMT.HE is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
33.33%
Diluted EPS growth of 33.33% while VALMT.HE is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
3.17%
Slight or no buybacks while VALMT.HE is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
3.17%
Diluted share change of 3.17% while VALMT.HE is zero. Bruce Berkowitz might see a minor difference that could widen over time.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
48.48%
OCF growth under 50% of VALMT.HE's 3866.67%. Michael Burry might suspect questionable revenue recognition or rising costs.
90.35%
FCF growth under 50% of VALMT.HE's 676.47%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-32.26%
Negative 10Y revenue/share CAGR while VALMT.HE stands at 21.60%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-5.25%
Negative 5Y CAGR while VALMT.HE stands at 25.40%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-11.00%
Negative 3Y CAGR while VALMT.HE stands at 0.72%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-29.11%
Negative 10Y OCF/share CAGR while VALMT.HE stands at 1436.68%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
520.62%
5Y OCF/share CAGR at 50-75% of VALMT.HE's 876.94%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
-45.68%
Negative 3Y OCF/share CAGR while VALMT.HE stands at 618.75%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
166.67%
Net income/share CAGR above 1.5x VALMT.HE's 47.43% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
700.00%
5Y net income/share CAGR above 1.5x VALMT.HE's 329.87%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
100.00%
3Y net income/share CAGR above 1.5x VALMT.HE's 61.06%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
54.65%
5Y equity/share CAGR above 1.5x VALMT.HE's 2.27%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
16.80%
3Y equity/share CAGR above 1.5x VALMT.HE's 4.04%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-6.70%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
3.35%
We show growth while VALMT.HE is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
3.19%
Asset growth above 1.5x VALMT.HE's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.43%
50-75% of VALMT.HE's 6.46%. Martin Whitman suspects weaker earnings or capital allocation vs. the competitor.
-2.92%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
-9.45%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.